Clinical Study

Circulating Biomarkers of Immune Activation Distinguish Viral Suppression from Nonsuppression in HAART-Treated Patients with Advanced HIV-1 Subtype C Infection

Table 1

CD4+ T-cell lymphocyte counts, HIV-1 viral loads, and circulating biomarkers of immune activation, in the 3 study groups.

MeasurementHIV Negative, Suppressed group, Failing group,
Pre-HAARTPost-HAART
MedianRange*MedianRange*MedianRange*MedianRange*

CD4+ T-cell countN/AN/A833–296208#86–537126#10–533
Viral loadN/AN/A53 0005700–330 000<50#7300#240–350 000
sCD144116.73185.7–5169.78815+4945.1–11 0008259.1+3424.7–11 0009209.8+430.5–11 000
2-microglobulin1.61.3–2.44.8+2.0–8.62.5+#1.7–3.63.3+#2–9.1
CRP4.00–15.11.80.1–43.83.90.3–30.23.20.5–97.3
TGF- 1 Total6458.81845.8–12 448.112 701.9+4634.8–37 587.214 882.2+4426.7–50 00011 399.3+0–43 434.5
IFN- 18.20–210.453.14.6–392.816.9#0–74.440.90–403.1
CXCL10416.1225.7–688.51864.0+858.3–66 740.7822.5+#212.2–1378.01097.0+#150.2–3957.1
CXCL9849.1246–2991.86059.5+1714.9–12 0002940.6+#1410.2–12 0004849.4+1 318–12 000
IFN- 18.016–28.219.411.7–64.916.814.3–54.717.314.3–120.1
IL-61.50.5–11.32.70.9–40.61.2#0.3–4.02.31.1–32.3
IL-100.90.4–14.92.50.5–26.21.40.6–2.62.2+0.8–9.6
CCL220.39.6–28.013.52.3–33.28.3+3.8–32.26.5+#1.4–46.9
CCL32.62.3–5.82.92.1–12.82.82.3–11.52.82.3–32.1
CCL439.823.5–70.422.8+0–82.048.8#7.6–84.133.94.4–110.3
TNF- 00–36.51.10–124.00#0–8.51.70–223.6
sTNF-R1353.2190.9–470.6512.2+212.3–800380.7#214.5–635.7363.5151.3–800

All results are presented as pg/mL with the exception of sCD14 (ng/mL), 2-microblobulin and CRP (µg/mL), circulating CD4+ T cell counts (cells/µL blood), and viral loads (copies/mL).
Range: minimum to maximum value.
for comparison with corresponding values for healthy control subjects.
for comparison with corresponding pre-HAART values.
Median concentrations were compared by means of Wilcoxon Mann-Whitney test for independent groups and Wilcoxon signed rank sum test for matched groups.